Form 4: AIM ImmunoTech Director Nancy Bryan Acquires Shares in Lieu of Cash Compensation
SEC Form 4
Director Nancy Bryan acquired 38,580 shares of AIM ImmunoTech Inc. common stock on February 28, 2025, in lieu of cash compensation under the company's Cash Conservation Plan.
Summary
- On February 28, 2025, Nancy Bryan, a director of AIM ImmunoTech Inc., acquired 38,580 shares of common stock.
- The shares were acquired at a price of $0.135 per share.
- This acquisition was made in lieu of director compensation, as part of the issuer's Cash Conservation Plan.
- Following the transaction, Ms. Bryan directly owns 246,983 shares of AIM ImmunoTech Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. A director acquiring shares can be seen as a positive sign, but it's part of a cash conservation plan, which might indicate financial constraints.
Positives
- The acquisition of shares by a director demonstrates confidence in the company.
- The Cash Conservation Plan helps the company manage its cash flow.
Industry Context
Directors often receive stock as part of their compensation, aligning their interests with those of shareholders. This is a common practice in publicly traded companies.
Stakeholder Impact
- Shareholders may view the director's share acquisition positively.
- The Cash Conservation Plan may impact employees if it involves cost-cutting measures.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transaction: Nancy Bryan acquired shares of AIM ImmunoTech Inc. |
| 03/04/2025 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.